Operating Lease, Right-of-Use Asset of Emergent BioSolutions Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Emergent BioSolutions Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Emergent BioSolutions Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $7,200,000, a 42% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Emergent BioSolutions Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,200,000 -$5,200,000 -42% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $7,700,000 -$6,000,000 -44% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $6,600,000 -$8,700,000 -57% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $11,700,000 -$4,500,000 -28% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $12,400,000 -$4,700,000 -27% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $13,700,000 -$2,000,000 -13% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $15,300,000 -$200,000 -1.3% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $16,200,000 -$3,200,000 -16% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $17,100,000 -$3,400,000 -17% 30 Sep 2023 10-Q 11 Dec 2023 2023 Q3
Q2 2023 $15,700,000 -$9,800,000 -38% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $15,500,000 -$11,400,000 -42% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $19,400,000 -$8,900,000 -31% 31 Dec 2022 10-K 08 Mar 2024 2023 FY
Q3 2022 $20,500,000 -$7,900,000 -28% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $25,500,000 -$4,100,000 -14% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $26,900,000 -$2,800,000 -9.4% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $28,300,000 -$2,700,000 -8.7% 31 Dec 2021 10-K/A 11 Dec 2023 2022 FY
Q3 2021 $28,400,000 +$5,000,000 +21% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $29,600,000 +$5,100,000 +21% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $29,700,000 +$4,100,000 +16% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $31,000,000 +$6,300,000 +26% 31 Dec 2020 10-Q 05 Nov 2021 2021 Q3
Q3 2020 $23,400,000 +$4,000,000 +21% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $24,500,000 +$8,800,000 +56% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $25,600,000 +$12,700,000 +98% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 $24,700,000 31 Dec 2019 10-Q 06 Nov 2020 2020 Q3
Q3 2019 $19,400,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $15,700,000 30 Jun 2019 10-Q 02 Aug 2019 2019 Q2
Q1 2019 $12,900,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.